Applications of L-Beta-Homoglutamic Acid Hydrochloride in Industrial Manufacturing

L-Beta-Homoglutamic Acid Hydrochloride serves as a key chemical intermediate in several highly specialized downstream applications, including pharmaceutical synthesis, peptide production, biotechnological research, nutraceutical formulation, and enzymatic assay development. As a direct manufacturer with established quality management systems, we supply this compound to partners requiring precise chemical characteristics and consistent batch-to-batch performance.

1. Pharmaceutical Intermediate for Antiepileptic Drug Synthesis

Our material serves in the synthesis of antiepileptic active pharmaceutical ingredients (APIs), where research and manufacturing teams use it as a chiral building block. It acts as a protected homolog of glutamic acid in multi-step reactions, forming key intermediates for drugs targeting central nervous system disorders. Manufacturers incorporate this compound at the stage of side chain elongation or functional group introduction before additional purification and API crystallization. High purity and compliance with international pharmacopoeias are critical throughout these processes.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP–NF Monographs for intermediates (when applicable)
• EDQM CEP and cGMP requirements
• FDA 21 CFR Part 211 (Quality System Regulation for finished pharmaceuticals)

Typical usage ratio

• Ranges from 0.8 to 1.1 molar equivalents, adjusted to yield and side reaction profile during batch or continuous production

Downstream process integration

• Introduced after initial scaffold assembly; used in amidation, coupling, or cyclization reaction steps, followed by in-process HPLC monitoring

Final product types

• Antiepileptic active pharmaceutical ingredients (APIs) and finished dosage forms such as tablets and injectables

2. Protected Amino Acid Reagent in Custom Peptide Manufacturing

Specialty peptide manufacturers use L-Beta-Homoglutamic Acid Hydrochloride as a nonproteinogenic amino acid, introducing structural variations or specific binding sites in synthetic peptides. This raw material enters solid phase peptide synthesis (SPPS) workflows, where its hydrochloride form offers improved solubility for solution-phase activation and coupling. Manufacturers utilize protected derivatives to minimize racemization and side reactions, ensuring targeted incorporation within complex peptide chains.

Industry compliance standards

• ISO 9001:2015 Quality Management System
• ICH Q11 Development and Manufacture of Drug Substances
• Peptide purity standards: ≥98% by HPLC (as per client or pharmacopeial requirements)
• FDA cGMP regulatory expectations for peptide APIs

Typical usage ratio

• 0.95–1.05 molar equivalents relative to growing peptide chain position, adjusted per desired sequence and scale

Downstream process integration

• Added to the automated synthesizer or batch reactor after appropriate side-chain protection; used during chain elongation phase

Final product types

• Therapeutic synthetic peptides, diagnostic oligopeptides, peptide-based research tools, custom research peptides

3. Biotechnological Research Reagent for Enzyme Assays

Life science laboratories and biotech manufacturers employ this compound as a structural analog in enzyme activity and inhibitor screening assays. L-Beta-Homoglutamic Acid Hydrochloride functions as a substrate analogue or modulator for glutamate-processing enzymes, supporting kinetic studies and structure-activity relationship analysis. Researchers dissolve precisely weighed quantities in assay buffers, where high purity guarantees repeatable assay outcomes.

Industry compliance standards

• ISO 13485 Quality Management for Medical Devices (when supplying reagents for diagnostics)
• Supplier certification for chemical traceability
• Research Use Only (RUO) and Analytical Grade conformity
• REACH compliance for laboratory chemical supply in the EU

Typical usage ratio

• Typically 1 μM to 10 mM in research assays; concentration varies according to enzyme kinetics and detection methods

Downstream process integration

• Dissolved directly into assay buffer or culture medium, often as part of screening panels for enzymatic reaction profiling and inhibitor validation

Final product types

• Diagnostic enzyme assay kits, inhibitor screening panels, customized biochemical research assay products

4. Nutraceutical Ingredient in Amino Acid Formulations

Producers of medical foods and specialized nutritional formulas incorporate L-Beta-Homoglutamic Acid Hydrochloride as a functional amino acid derivative. Its structural resemblance to glutamic acid allows its use in amino acid blends targeting neurological health and metabolic support. Manufacturers blend this ingredient into powdered or liquid formulations under controlled environmental and contamination conditions, followed by comprehensive compositional analysis and labeling verification to meet food additive and nutraceutical regulations.

Industry compliance standards

• ISO 22000:2018 Food Safety Management System
• US FDA 21 CFR Part 101 (Food labeling requirements for medical foods and supplements)
• EU Regulation (EC) No 1333/2008 (Food Additives)
• Hazard Analysis Critical Control Point (HACCP) compliance for ingredient handling

Typical usage ratio

• Formulated at 0.02%–0.1% w/w in amino acid blends depending on nutritional claims and regional food standard limits

Downstream process integration

• Metered addition to bulk amino acid premix tanks prior to final blending; subject to batch-to-batch nutrient content testing and allergen control procedures

Final product types

• Medical nutrition powder, amino acid supplement drink mixes, specialized clinical nutrition products